1 / 21

HEPATORENAL SYNDROME – LIVER PERSPECTIVE

HEPATORENAL SYNDROME – LIVER PERSPECTIVE. By. Dr. S. Shivakumar M.D., Addl. Professor of Medicine, Govt.Stanley Medical College, Chennai – 600 001. HRS-TYPES. Type I – HRS Rapidly progressive Renal Failure with a doubling of S.Cr. > 2.5mg/dl or  Ccr < 20ml/min in < 2 weeks.

tale
Télécharger la présentation

HEPATORENAL SYNDROME – LIVER PERSPECTIVE

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. HEPATORENAL SYNDROME – LIVER PERSPECTIVE By Dr. S. Shivakumar M.D., Addl. Professor of Medicine, Govt.Stanley Medical College, Chennai – 600 001.

  2. HRS-TYPES • Type I – HRS • Rapidly progressive Renal Failure with a doubling of S.Cr. > 2.5mg/dl or •  Ccr < 20ml/min in < 2 weeks. • Type II HRS • Slowly progressive  S.Cr to > 1.5mg/dl (or ) • Ccr < 40ml/min in the absence of other potential causes of Renal Failure. • Liver Criteria • Chronic or Acute liver disease with Liver failure & PHT

  3. DEFINITION OF HRS • HRS Type II • Status of Ascites (Refractory) to be clarified • HRS Type I • Not clear whether type I & II HRS are two distinct entities or two different stages. • Role of precipitating factors not defined. • Does not explain what determines whether a patient will gradually evolve into Type II HRS with progressive worsening GFR or acutely develop Renal Failure with its grave prognosis.

  4. PATHOGENESIS Sinusoidal PHT + Severe Hepatic decompensation Splanchnic Arterial Vasdilatation ++ Central Arterial Hypovolemia Sympathetic Activation / Renin / Angiotensin / Aldosterone / ADH Renal vasoconstriction  Intra Renal - Vasoconstrictors /  Vasodilators Renal Vasoconstriction HRS

  5. SINUSOIDAL PHT & SEVERE HEPATIC DECOMPENSATION A.POST SINUSOIDAL PHT • HRS has been successful treated by TIPS • Occlusion of TIPS by angioplasty balloon Acute reduction of Renal Blood Flow (RBF) • Release of balloon with elimination of PHT RBF returned to baseline • Presinusoidal PHT - Not associated with HRS. • Hepato-Renal Reflex – Sympathetic / Adenosine. • Sectioning the Renal Sympathetic supply abolished Renal effectimproves Renal function in HRS.

  6. SINUSOIDAL PHT & SEVERE HEPATIC DECOMPENSATION B. ACUTE HEPATITIS – Alcoholic Hepatitis • TNF - Imp. mediator of Circulatory disturbance   Vascular permeability & Vasodilation  NO  HRS • Acute TNF therapy (Infiximab)  Improves Systemic haemodynamic derangement [Mokeyer et al (Gut 2003; 52:1182-1187)]

  7. SINUSOIDAL PHT & SEVERE HEPATIC DECOMPENSATION C. ACUTE LIVER FAILURE • Induced by hepatotoxin – Galactosamine • Acute Liver failure •  Endothelin  HRS. • Improved by bosentan ( R.Anand et al GUT 2002;50: 111-117) • Acute Liver failure • Intrahepatic portosystemic Vasodialtion  HRS (P Javle et al GUT 1998 ; 272 – 279)

  8. SINUSOIDAL PHT & SEVERE HEPATIC DECOMPENSATION • liver borne diuretic factor (LBDF) •  synthesis •  Bilirubin • Predisposes to HRS. • Renal vasoconstrictors • Not metabolized in liver. • Blockade of Natriuretic peptide receptors •  RBF &  GFR

  9. HRS-TYPE 2- PATHOGENESIS • Extreme Over activity of endogenous vasoconstrictor system  overcomes the Intra Renal Vasodilatory mechanism. • Na retention is intense  Refractory Ascites • Survival • 50% - 5 months • 20% -1yr

  10. ASCITES AND HRS

  11. TYPE – 1 HRS TYPE 1 HRS (S.Cr. > 2.5mg/dl in < 2 Weeks) • Although it can arise spontaneously, it is frequently associated with a precipitating factor. • Reversible with Vasoconstrictor & Does not recur FIRST & SECOND HIT HYPOTHESIS OF HRS (2-Hit hypothesis) FIRST HIT • Splanchnic & Systemic vasodilation • ( EABV) Liver dysfunction Sinusoidal pH

  12. (Contd..) HRS – Mechanism SECOND HIT  Spontaneous Bacterial Peritonitis • Factors Exaggerating  EABV • Overdiuresis • Large volume paracentesis • G.I.Bleed • Cholestatic jaundice • Nephrotoxic drugs • Idiopathic-24% ( Florence Wong &Laurence Blendis – Hepatology 2001 34 ; 6 :1242-1251)

  13. 2 HIT HYPOTHESIS SPONTANEOUS BACTERIAL PERITONITIS G.I. BLEED  EABV NEPHROTOXIC DRUGS OVER DIURESIS CHOLESTASIS LARGE VOLUME PARACENTESIS First Hit Second Hit

  14. SPONTANEOUS BACTERIAL PERITONITIS (SBP) • 30% of patients with SBP  HRS despite adequate treatment • Sepsis (SIRS)  Production of cytokinesEndotoxins  Production of N.O. Arterial Vasodilatation • Important Predictors •  Creatinine before infection. •  Bilirubin > 4mg/dl (cholestasis) • Intestinal decontamination with Antibiotics & Volume expansion with IV Albumin  Improves Splanchnic Haemodynamics

  15. CHOLESTASIS (S.BILIRUBIN >4MG/DL) • Cholestasis (In the absence of PHT) Vasodilatation & impaired Vascular responsiveness to Circulating Vasoconstrictors. • Cholestasis + PHT Complements Circulatory changes  Type 1 HRS • Cholestasis + Cirrhosis Predisposes to HRS • Cholestasis + other 2nd Hit Risk factors  Predisposes to HRS

  16. (Contd..) CHOLESTASIS • Other mechanisms • Endotoxemia • Nephrotoxic effect of  Bile acids • Disturbance of Renal Prostaglandins & Thromboxane Synthesis. • Hepatitis (Alcoholic, Toxic, Viral) + Sinusoidal PHT  HRS common

  17. GASTROINTESTINAL BLEED •  Acute Blood loss •  GFRATN •  GFR Type 1 HRS • Decompensated Cirrhosis with Variceal Bleed Develop Systemic inflammatory Response syndrome (SIRS) Cytokine  NO exacerbates hyperdynamic response • Predictor of HRS  Renal function before GI bleed • SIRS - Fever / Tachycardia / Tachypnoea / Leucocytosis • Treatment- antibiotics protect circulating Blood volume. • Prophylactic Oral Antibiotics reduces SBP.

  18. DIURETICS •  Higher incidence of renal impairment in hospitalised patients with tense ascites treated with Diuretics compared to Paracentesis. •  Plasma renin activity - Esp.when there is no peripheral edema. • Diuretics + AlbuminPrevents HRS • Diuretics have other effects on kidney apart from Intravascular volume.

  19. LARGE VOL. PARACENTESIS(LVP) • Large volume paracentesis  GFR • Exaggeration of Arterial vasodilatation  Stimulation of vasconstrictors system • Only 32% - had activation of vasoconstrictor system. • Depends on Hemodynamic stability before paracentesis ( PRA) • Treat with 6-8g IV Albumin with LVP

  20. Acute Renal Failure Fe Na < 1% > 1% CVP ATN < 5mmHg > 10mm Pre renal Azotemia HRS

  21. CONCLUSIONS • Definition of HRS - Evolve definite Liver criteria • Type 2 HRS - Refractory Ascites usually associated • Type 1 HRS - ‘TWO HIT’ Hypothesis - precipitating factors • Arterial Vasodilatation (Splanchnic & Systemic) -important mechanism for HRS • Other Mechanisms  Hepato renal Reflex,TNF, Endothelin, Bilirubiin, Liver borne Diuretic factor

More Related